{{Rsnum
|rsid=17746001
|Chromosome=4
|position=179734472
|Orientation=plus
|GMAF=0.05739
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.8 | 14.2 | 0.0
| HCB | 91.2 | 8.8 | 0.0
| JPT | 94.6 | 5.4 | 0.0
| YRI | 96.6 | 3.4 | 0.0
| ASW | 94.6 | 5.4 | 0.0
| CHB | 91.2 | 8.8 | 0.0
| CHD | 87.0 | 13.0 | 0.0
| GIH | 87.1 | 12.9 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 63.2 | 36.8 | 0.0
| MKK | 94.2 | 5.8 | 0.0
| TSI | 87.3 | 11.8 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=T
|Pval=3E-7
|OR=1.7500
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}